Fig. 4From: FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cellsFOLR1 expression correlated with patient treatment efficacy (a) and drug resistance (b).*, P = 0.001, compared with CR + PR + SD; ▲, P = 0.000, compared with drug sensitive. CR, complete response. PR, partial response.SD, stable disease. PD, progressive diseaseBack to article page